Does atherosclerosis contribute the development of Fahr's Syndrome?

Area of Science:

• Neurology
• Endocrinology
• Radiology

Background:

• Fahr's syndrome is a rare neurological disorder characterized by abnormal calcification in the brain's basal ganglia and cerebellum.
• Impaired glucose tolerance (IGT) is associated with atherosclerosis, potentially leading to multi-organ complications.
• Hypoparathyroidism, a condition of insufficient parathyroid hormone, can affect calcium and phosphate levels, impacting vascular health.

Observation:

• A 52-year-old male presented with Fahr's syndrome, hypoparathyroidism, and IGT, exhibiting a normal neurological exam except for bilateral tremor.
• Laboratory results revealed low serum calcium (5.9 mg/dl) and parathormone (1.95 pg/ml) levels, with normal phosphate (5.45 mg/dl).
• Cranial CT and MRI confirmed bilateral, symmetric calcifications in the basal ganglia, centrum semiovale, and cerebellum.

Findings:

• The patient was diagnosed with Fahr's syndrome, hypoparathyroidism, and IGT.
• Treatment was initiated under the guidance of an endocrinologist.
• The case suggests a potential link between IGT-induced atherosclerosis and the vascular calcification observed in Fahr's syndrome.

Implications:

• This case underscores the importance of investigating metabolic factors like IGT in patients with Fahr's syndrome.
• Further research is needed to elucidate the precise pathogenic mechanisms connecting IGT, atherosclerosis, and Fahr's syndrome.
• Understanding these associations may lead to improved diagnostic and therapeutic strategies for this rare neurological condition.